MCPMF (Mochida Pharmaceutical Co) E10: $0.60 (As of Mar. 2026)


MCPMF Mochida Pharmaceutical Co Ltd MCPMF
69 GF Score
Price $9.60
GF Value $11.22
! 4 Warning Signs
View Full Analysis

What is Mochida Pharmaceutical Co E10?

Mochida Pharmaceutical Co MCPMF 69 E10 is $0.60 as of Mar. 2026. GuruFocus rates MCPMF with a GF Score™ of 69/100 and a GF Value™ of $11.22. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mochida Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.278. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.60 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Mochida Pharmaceutical Co's average E10 Growth Rate was 0.90% per year. During the past 3 years, the average E10 Growth Rate was -0.70% per year. During the past 5 years, the average E10 Growth Rate was -0.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Mochida Pharmaceutical Co was 2.70% per year. The lowest was -0.90% per year. And the median was 0.15% per year.

As of today (2026-07-11), Mochida Pharmaceutical Co's current stock price is $9.60. Mochida Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was $0.60. Mochida Pharmaceutical Co's Shiller PE Ratio of today is 16.00.

During the past 13 years, the highest Shiller PE Ratio of Mochida Pharmaceutical Co was 27.34. The lowest was 13.72. And the median was 16.71.


Mochida Pharmaceutical Co  (OTCPK:MCPMF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mochida Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=9.60/0.60
=16.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Mochida Pharmaceutical Co was 27.34. The lowest was 13.72. And the median was 16.71.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Mochida Pharmaceutical Co E10 Related Terms


Mochida Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Mochida Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mochida Pharmaceutical Co E10 Chart

Mochida Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.63 0.63 0.65 0.60

Mochida Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.68 0.64 0.57 0.60

MCPMF vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mochida Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mochida Pharmaceutical Co's Shiller PE Ratio falls into.


MCPMF
69GF Score
Mochida Pharmaceutical Co Ltd MCPMF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mochida Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mochida Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.278/112.7000*112.7000
=0.278

Current CPI (Mar. 2026) = 112.7000.

Mochida Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.783 98.100 0.900
201609 0.566 98.000 0.651
201612 0.919 98.400 1.053
201703 -0.283 98.100 -0.325
201706 0.981 98.500 1.122
201709 0.365 98.800 0.416
201712 0.747 99.400 0.847
201803 -0.059 99.200 -0.067
201806 1.337 99.200 1.519
201809 0.245 99.900 0.276
201812 0.654 99.700 0.739
201903 -0.324 99.700 -0.366
201906 0.780 99.800 0.881
201909 0.305 100.100 0.343
201912 0.419 100.500 0.470
202003 -0.427 100.300 -0.480
202006 0.808 99.900 0.912
202009 0.499 99.900 0.563
202012 0.747 99.300 0.848
202103 0.043 99.900 0.049
202106 0.630 99.500 0.714
202109 0.537 100.100 0.605
202112 1.211 100.100 1.363
202203 0.087 101.100 0.097
202206 0.627 101.800 0.694
202209 0.144 103.100 0.157
202212 0.829 104.100 0.897
202303 -0.293 104.400 -0.316
202306 0.327 105.200 0.350
202309 0.217 106.200 0.230
202312 0.313 106.800 0.330
202403 0.019 107.200 0.020
202406 0.278 108.200 0.290
202409 0.251 108.900 0.260
202412 0.510 110.700 0.519
202503 0.015 111.100 0.015
202506 0.370 111.700 0.373
202509 0.374 112.000 0.376
202512 0.450 113.000 0.449
202603 0.278 112.700 0.278

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.60 mean?
Mochida Pharmaceutical Co (MCPMF) has a E10 of $0.60 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Mochida Pharmaceutical Co and its competitors.
Is Mochida Pharmaceutical Co's E10 too high?
Mochida Pharmaceutical Co's current E10 is $0.60. Overall, Mochida Pharmaceutical Co has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Mochida Pharmaceutical Co's E10 compare to ZTS and UTHR?
Mochida Pharmaceutical Co's E10 of $0.60 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Mochida Pharmaceutical Co and its competitors. Mochida Pharmaceutical Co's current E10 is $0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mochida Pharmaceutical Co stock overvalued right now?
Mochida Pharmaceutical Co (MCPMF) has a current E10 of $0.60. The stock's GF Value™ is $11.22, compared to a current price of $9.60 — trading 14.4% below its estimated fair value. The current E10 is $0.60. Mochida Pharmaceutical Co's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Mochida Pharmaceutical Co (MCPMF), the current E10 is $0.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mochida Pharmaceutical Co (MCPMF) Overvalued in 2026?

Based on GuruFocus' analysis, Mochida Pharmaceutical Co stock appears to be undervalued. The current stock price of $9.60 is trading 14.4% below its estimated GF Value™ of $11.22.

Key valuation signals for MCPMF:

  • E10: $0.60
  • GF Value™: $11.22 vs. price of $9.60 (14.4% below fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the MCPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mochida Pharmaceutical Co Business Description

Other Exchanges 4534:Japan
Address 1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
69GF Score

Get the complete analysis for MCPMF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.60
Price
$11.22
GF Value